Zura Bio Limited (94E.F)

EUR 1.28

(5.79%)

Operating Expenses Summary of Zura Bio Limited

  • Zura Bio Limited's latest annual operating expenses in 2023 was 62.63 Million USD , N/A from previous year.
  • Zura Bio Limited's latest quarterly operating expenses in 2024 Q2 was 11.75 Million USD , up 40.34% from previous quarter.
  • Zura Bio Limited reported a annual operating expenses of 2.67 Million USD in annual operating expenses 2022, down 0.0% from previous year.
  • Zura Bio Limited reported a annual operating expenses of 1.09 Million USD in annual operating expenses 2021, N/A from previous year.
  • Zura Bio Limited reported a quarterly operating expenses of 8.37 Million USD for 2024 Q1, down -22.61% from previous quarter.
  • Zura Bio Limited reported a quarterly operating expenses of 10.18 Million USD for 2023 Q3, down -69.95% from previous quarter.

Annual Operating Expenses Chart of Zura Bio Limited (2023 - 2021)

Historical Annual Operating Expenses of Zura Bio Limited (2023 - 2021)

Year Operating Expenses Operating Expenses Growth
2023 62.63 Million USD N/A
2022 2.67 Million USD 0.0%
2021 1.09 Million USD N/A

Peer Operating Expenses Comparison of Zura Bio Limited

Name Operating Expenses Operating Expenses Difference
BioNTech SE 2.52 Billion EUR 97.523%
CureVac N.V. 211.75 Million EUR 70.419%
Biotest Aktiengesellschaft 136.8 Million EUR 54.212%
Biotest Aktiengesellschaft 136.8 Million EUR 54.212%
BRAIN Biotech AG 24.94 Million EUR -151.145%
Formycon AG 23.73 Million EUR -163.928%
Heidelberg Pharma AG 27.81 Million EUR -125.188%
Medigene AG 20.54 Million EUR -204.956%